Detalhe da pesquisa
1.
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
PLoS Pathog
; 17(2): e1009257, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33556148
2.
Host innate and adaptive immunity shapes the gut microbiota biogeography.
Microbiol Immunol
; 66(6): 330-341, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35067963
3.
Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
J Virol
; 93(7)2019 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30651354
4.
Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia.
J Immunol
; 196(6): 2655-65, 2016 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26864029
5.
Analysis of the intestinal microbial community and inferred functional capacities during the host response to Pneumocystis pneumonia.
Exp Lung Res
; 42(8-10): 425-439, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27925857
6.
Human Immunodeficiency Virus Infection and Host Defense in the Lungs.
Semin Respir Crit Care Med
; 37(2): 147-56, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26974294
7.
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.
Nat Commun
; 14(1): 4789, 2023 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37553348
8.
T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers.
Nat Med
; 26(6): 932-940, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32393800
9.
Striking a balance in an antibody network: A roadmap for HIV-1 vaccines.
J Clin Invest
; 129(11): 4580-4582, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31589166
10.
CD4(+) T-Cell-Independent Secondary Immune Responses to Pneumocystis Pneumonia.
Front Immunol
; 7: 178, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27242785